Page last updated: 2024-08-21

pyrazines and Acute Kidney Failure

pyrazines has been researched along with Acute Kidney Failure in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.26)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (17.02)	29.6817
2010's	31 (65.96)	24.3611
2020's	6 (12.77)	2.80

Authors

Authors	Studies
Chalermphunchai, N; Lelamali, K; Noppakun, K; Sawangduan, V; Sinpanee, T; Vongchaiudomchoke, T	1
Chen, Y; Han, Y; Qian, X; Wu, J; Yang, Q; Ying, J; Zhang, Y; Zhu, H	1
Du, P; Han, H; Hou, Y; Jiang, G; Meng, X; Sun, W; Wang, L; Xin, R; Yuan, W; Zhang, L	1
Baggett, MV; Rhee, EP; Shepard, JO; Sise, ME; Stevens, JS	1
Dong, M; Du, P; Li, A; Qi, F; Sun, W; Sun, X; Wang, L; Wang, Z; Zhang, Y	1
Bayrakci, B; Cengiz, AB; Gülhan, B; Gürlevik, SL; Kesici, S; Kurt Sukur, ED; Oygar, PD; Ozen, S; Ozsurekci, Y; Topaloglu, R	1
Cao, W; Chen, W; Ding, M; Guo, H; Lin, T; Wang, T; Wei, H; Yu, H; Zhang, C; Zhao, S; Zhao, X	1
Fu, D; Gong, X; Lu, H; Norgren, S; Tang, X; Wang, G; Wang, Q; Wang, Y	1
Ahn, SY; Chae, DW; Chin, HJ; Han, JS; Joo, KW; Kim, S; Lee, J; Na, KY	1
Aljama, P; Alonso, C; Alvarez-Lara, MA; Caballero-Villarraso, J; Carracedo, J; Martín-Malo, A; Ojeda-López, R; Pendón-Ruiz de Mier, MV	1
Caba-Molina, M; Claver-Ferré, C; García-Marcos, SA; Gómez-Morales, M; Martín-Gómez, MA; Palacios-Gómez, ME	1
Devine, E; Krause, B; Krieter, DH; Lemke, HD; Storr, M; Wanner, C	1
Liu, G; Liu, L; Wang, SX; Wang, Y; Yao, Y; Zhang, YK	1
Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ghosh, A; Ingelfinger, JR; Lo, CS; Otoukesh, A; Shi, Y; Zhang, SL	1
Guan, M; Li, C; Li, J; Lyv, F; Wang, C; Xue, Y; Zeng, Y; Zheng, Z	1
Hobeika, L; Self, SE; Velez, JC	1
Cheungpasitporn, W; Fervenza, FC; Gertz, MA; Leung, N; Sethi, S	1
Kao, DP; Kohrt, HE; Kugler, J	1
Al-Husseini, I; Al-Salam, S; Ali, BH; Nemmar, A	1
Lattin, G; Sanders, O; Timpone, V	1
Gay, F; Palumbo, A	1
Adam, Z; Autzinger, EM; Egyed, M; Gisslinger, H; Greil, R; Hajek, R; Keil, F; Lang, A; Ludwig, H; Thaler, J; Tóthová, E; Womastek, I; Zojer, N	1
Bocchia, M; Crupi, R; Defina, M; Gozzetti, A	1
Arai, J; Emi, N; Hasegawa, M; Hiki, Y; Ishii, J; Kato, M; Kondo, F; Murakami, K; Nabeshima, K; Nakai, S; Ohashi, A; Sugiyama, S; Tomita, M; Yamamoto, K; Yuzawa, Y	1
Fukami, K; Koike, K; Morishige, S; Okamura, T; Okuda, S; Taguchi, K; Yakushiji, K	1
Alvarez Fernández, GM; de Alarcón Jiménez, RM; García Hernández, MA; Jimeno Griñó, C; Molina Núñez, M; Navarro Parreño, MJ; Roca Meroño, S; Zarco Pedrinaci, E	1
Gharwan, H; Truica, CI	1
Burnette, BL; Leung, N; Rajkumar, SV	1
Cserti-Gazdewich, C; Dzik, WH; Haspel, RL	1
Bridoux, F; Fermand, JP; Hutchison, C	1
Chen, W; Fenton, C; Haffner, SM; Pendergrass, M	1
Airia, P; Cockwell, P; Cook, M; Grima, D; Heyne, N; Hutchison, CA; Schindler, R; Zickler, D	1
Silvennoinen, R; Sinisalo, M; Wirta, O	1
Juul, JS; Larsen, T; Marcussen, N; Pedersen, EB	1
Crotty, TB; Dunne, O; Fennelly, D; Holian, J; Ward, F; Watson, A	1
Cockwell, P; Cook, M; Stringer, S	1
Bladé, J; Dimopoulos, MA; Kastritis, E	1
Cockwell, P; Cook, M	1
Haynes, R; Kyle, R; Leung, N; Winearls, CG	1
Mahé, E; Sigal, ML; Sin, C	1
Bagot, M; Bezier, M; Cordoliani, F; Delyon, J; Malphettes, M; Rybojad, M; Szalat, R	1
Chung, HC; Kim, DH; Kim, EJ; Kim, SG; Kim, SH; Kim, YG; Lee, EJ; Lee, I; Lee, MG	1
Bae, SK; Kim, JW; Kim, SG; Kim, YH; Lee, MG; Lee, SJ	1
Chung, HC; Kim, DH; Kim, EJ; Kim, SG; Kim, SH; Kim, YG; Lee, EJ; Lee, MG; Lees, I	1
Drach, J; Graf, H; Lang, A; Ludwig, H; Meran, JG	1
Weinman, EJ	1
Brade, W; Propping, P	1

Reviews

6 review(s) available for pyrazines and Acute Kidney Failure

Article	Year
How to treat elderly patients with multiple myeloma: combination of therapy or sequencing. Hematology. American Society of Hematology. Education Program, 2009 Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Comorbidity; Disease Management; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Myeloablative Agonists; Peripheral Nervous System Diseases; Pyrazines; Randomized Controlled Trials as Topic; Remission Induction; Thalidomide; Transplantation Conditioning; Venous Thrombosis	2009
[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:2 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Chronic Disease; Combined Modality Therapy; Dexamethasone; Down-Regulation; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin lambda-Chains; Kidney Diseases; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pyrazines; Remission Induction; Renal Dialysis; Transplantation, Autologous	2011
Achieving an early myeloma response in patients with kidney impairment. Advances in chronic kidney disease, 2012, Volume: 19, Issue:5 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Doxorubicin; Glomerular Filtration Rate; Humans; Lenalidomide; Multiple Myeloma; Pyrazines; Thalidomide; Time Factors	2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspective. Advances in chronic kidney disease, 2012, Volume: 19, Issue:5 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Doxorubicin; Humans; Lenalidomide; Multiple Myeloma; Oligopeptides; Pyrazines; Thalidomide	2012
The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney. Advances in chronic kidney disease, 2012, Volume: 19, Issue:5 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Humans; Immunoglobulin Light Chains; Multiple Myeloma; Plasma Exchange; Pyrazines; Renal Dialysis	2012
Myeloma kidney: improving clinical outcomes? Advances in chronic kidney disease, 2012, Volume: 19, Issue:5 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Humans; Immunoglobulin Light Chains; Immunosuppressive Agents; Multiple Myeloma; Plasma Exchange; Prognosis; Proteasome Inhibitors; Pyrazines; Renal Dialysis; Stem Cell Transplantation	2012

Trials

2 trial(s) available for pyrazines and Acute Kidney Failure

Article	Year
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatric nephrology (Berlin, Germany), 2021, Volume: 36, Issue:11 Topics: Acute Kidney Injury; Adenosine Monophosphate; Adolescent; Alanine; Amides; Child; COVID-19; COVID-19 Drug Treatment; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Male; Pyrazines; Renal Elimination; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Treatment Outcome	2021
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-20, Volume: 28, Issue:30 Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Disease-Free Survival; Doxorubicin; Europe; Female; Glomerular Filtration Rate; Humans; Immunoglobulin Light Chains; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Proportional Hazards Models; Prospective Studies; Protease Inhibitors; Pyrazines; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2010

Article

Year

Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

Pediatric nephrology (Berlin, Germany), 2021, Volume: 36, Issue:11

Topics: Acute Kidney Injury; Adenosine Monophosphate; Adolescent; Alanine; Amides; Child; COVID-19; COVID-19 Drug Treatment; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Male; Pyrazines; Renal Elimination; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Treatment Outcome

2021

Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-20, Volume: 28, Issue:30

Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Disease-Free Survival; Doxorubicin; Europe; Female; Glomerular Filtration Rate; Humans; Immunoglobulin Light Chains; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Proportional Hazards Models; Prospective Studies; Protease Inhibitors; Pyrazines; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2010

Other Studies

39 other study(ies) available for pyrazines and Acute Kidney Failure

Article	Year
Modification of immunosuppressive agents in a kidney transplant recipient with COVID-19 and acute kidney injury. Journal of infection in developing countries, 2021, 09-30, Volume: 15, Issue:9 Topics: Acute Kidney Injury; Adult; Amides; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Lopinavir; Male; Mycophenolic Acid; Pyrazines; Ritonavir; Steroids; Tacrolimus; Thailand; Transplant Recipients	2021
Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury. Molecular and cellular biochemistry, 2020, Volume: 464, Issue:1-2 Topics: Acute Kidney Injury; Animals; Caspase 3; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Pyrazines; Receptors, N-Methyl-D-Aspartate; Sepsis	2020
Ligustrazine ameliorates acute kidney injury through downregulation of NOD2‑mediated inflammation. International journal of molecular medicine, 2020, Volume: 45, Issue:3 Topics: Acute Kidney Injury; Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Immunohistochemistry; In Situ Nick-End Labeling; Male; Nod2 Signaling Adaptor Protein; Pyrazines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction	2020
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury. The New England journal of medicine, 2020, May-28, Volume: 382, Issue:22 Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Amides; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Betacoronavirus; Continuous Renal Replacement Therapy; Coronavirus Infections; COVID-19; Creatinine; Humans; Hypertension; Lung; Male; Obesity; Pandemics; Pneumonia, Viral; Pyrazines; Radiography, Thoracic; SARS-CoV-2	2020
Tetramethylpyrazine alleviates acute kidney injury by inhibiting NLRP3/HIF‑1α and apoptosis. Molecular medicine reports, 2020, Volume: 22, Issue:4 Topics: Acute Kidney Injury; Animals; Case-Control Studies; Cell Line; Cell Survival; Down-Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Injections, Intraperitoneal; Kidney Tubules, Proximal; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury	2020
Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis. Biomaterials, 2019, Volume: 219 Topics: Acute Kidney Injury; Animals; Antioxidants; Fibrosis; Mice; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Reperfusion Injury; Thiones; Thiophenes; Time Factors; Tissue Distribution; Treatment Outcome	2019
Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways. American journal of nephrology, 2013, Volume: 37, Issue:3 Topics: Acute Kidney Injury; Animals; Apoptosis; Contrast Media; Disease Models, Animal; Forkhead Transcription Factors; Immunohistochemistry; Kidney Cortex Necrosis; Male; Microscopy, Electron, Transmission; Nerve Tissue Proteins; p38 Mitogen-Activated Protein Kinases; Pyrazines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction	2013
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney. BMC nephrology, 2013, Apr-27, Volume: 14 Topics: Acute Kidney Injury; Animals; Dipeptidyl-Peptidase IV Inhibitors; Forkhead Box Protein O3; Forkhead Transcription Factors; Kidney; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles	2013
Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6 Topics: Acute Kidney Injury; Adsorption; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Female; Hemodiafiltration; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Ion Exchange Resins; Male; Membranes, Artificial; Middle Aged; Multiple Myeloma; Myeloma Proteins; Polymers; Pyrazines; Serum Albumin; Thalidomide; Treatment Outcome	2013
Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6 Topics: Acute Kidney Injury; Anemia; Biopsy; Boronic Acids; Bortezomib; Dexamethasone; Drug Monitoring; Drug Substitution; Flank Pain; Humans; Immunoglobulin kappa-Chains; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pyrazines; Renal Dialysis; Thalidomide	2013
Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysis. Artificial organs, 2014, Volume: 38, Issue:10 Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Male; Middle Aged; Models, Theoretical; Multiple Myeloma; Pyrazines; Renal Dialysis; Thalidomide	2014
Acquired Fanconi syndrome with proximal tubular cytoplasmic fibrillary inclusions of λ light chain restriction. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:2 Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Boronic Acids; Bortezomib; Cytoplasm; Dexamethasone; Fanconi Syndrome; Humans; Immunoglobulin Light Chains; Kidney Tubules, Proximal; Male; Microscopy, Fluorescence; Microscopy, Immunoelectron; Multiple Myeloma; Myeloma Proteins; Phagosomes; Proteinuria; Pyrazines; Thalidomide	2014
Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes, 2014, Volume: 63, Issue:10 Topics: Acute Kidney Injury; Angiotensinogen; Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Gene Expression; Hypertension; Kidney Tubules, Proximal; Mice; Mice, Transgenic; NF-E2-Related Factor 2; NF-kappa B; Pyrazines; Reverse Transcriptase Inhibitors; Signal Transduction; Thiones; Thiophenes	2014
The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice. International journal of molecular sciences, 2014, Jun-26, Volume: 15, Issue:7 Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Dipeptidyl-Peptidase IV Inhibitors; Dyslipidemias; Fibronectins; Kidney; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrazines; Sitagliptin Phosphate; Transforming Growth Factor beta1; Triazoles	2014
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma. BMC nephrology, 2014, Sep-30, Volume: 15 Topics: Acute Kidney Injury; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Edema; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Renal; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Podocytes; Proteasome Inhibitors; Proteinuria; Pyrazines; Recurrence; Shock, Septic; Teniposide; Thalidomide; Thrombotic Microangiopathies	2014
Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy. Clinical nephrology, 2015, Volume: 83, Issue:6 Topics: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Atypical Hemolytic Uremic Syndrome; Boronic Acids; Bortezomib; Humans; Male; Middle Aged; Paraproteinemias; Pyrazines	2015
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:10 Topics: Acute Kidney Injury; Aged; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrazines; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles	2008
Comparative protective effect of N-acetyl cysteine and tetramethylpyrazine in rats with gentamicin nephrotoxicity. Journal of applied toxicology : JAT, 2009, Volume: 29, Issue:4 Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Body Weight; Creatinine; Gentamicins; Kidney Cortex; Male; Protective Agents; Protein Synthesis Inhibitors; Pyrazines; Rats; Rats, Wistar; Urea; Urodynamics	2009
Worsening low back pain. The Journal of family practice, 2009, Volume: 58, Issue:7 Topics: Acute Kidney Injury; Adult; Biopsy, Needle; Bone Marrow; Boronic Acids; Bortezomib; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Disease Progression; Family Practice; Follow-Up Studies; Humans; Immunohistochemistry; Kidney Function Tests; Low Back Pain; Male; Multiple Myeloma; Pain Measurement; Plasmapheresis; Pyrazines; Renal Dialysis; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed	2009
Lenalidomide efficacy in bortezomib-resistant myeloma. Nature reviews. Clinical oncology, 2010, Volume: 7, Issue:9 Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Resistance, Neoplasm; Gene Deletion; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines; Risk Factors; Thalidomide; Treatment Failure	2010
Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2010, Volume: 14, Issue:5 Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Dexamethasone; Drug Therapy, Combination; Female; Hemodiafiltration; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Multiple Myeloma; Plasma Exchange; Pyrazines; Treatment Outcome	2010
[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2011, Jan-10, Volume: 100, Issue:1 Topics: Acute Kidney Injury; Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Injections, Intravenous; Male; Multiple Myeloma; Pyrazines; Zoledronic Acid	2011
Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Acute Kidney Injury; Antineoplastic Agents; Boronic Acids; Bortezomib; Diagnosis, Differential; Humans; Immunoglobulin kappa-Chains; Male; Middle Aged; Multiple Myeloma; Prognosis; Pyrazines; Remission Induction	2012
Renal improvement in myeloma with bortezomib plus plasma exchange. The New England journal of medicine, 2011, Jun-16, Volume: 364, Issue:24 Topics: Acute Kidney Injury; Antineoplastic Agents; Biomarkers; Boronic Acids; Bortezomib; Combined Modality Therapy; Glomerular Filtration Rate; Humans; Immunoglobulin Light Chains; Multiple Myeloma; Plasma Exchange; Pyrazines	2011
Renal improvement in myeloma with plasma exchange. The New England journal of medicine, 2011, 09-15, Volume: 365, Issue:11 Topics: Acute Kidney Injury; Antineoplastic Agents; Boronic Acids; Bortezomib; Combined Modality Therapy; Humans; Multiple Myeloma; Plasma Exchange; Pyrazines	2011
Renal improvement in myeloma with plasma exchange. The New England journal of medicine, 2011, 09-15, Volume: 365, Issue:11 Topics: Acute Kidney Injury; Antineoplastic Agents; Boronic Acids; Bortezomib; Combined Modality Therapy; Humans; Immunoglobulin Light Chains; Multiple Myeloma; Plasma Exchange; Pyrazines	2011
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis. Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:7 Topics: Acute Kidney Injury; Adolescent; Adult; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Labeling; Exenatide; Female; Humans; Incidence; Male; Middle Aged; Peptides; Proportional Hazards Models; Pyrazines; Retrospective Studies; Risk Assessment; Sitagliptin Phosphate; Triazoles; Venoms; Young Adult	2012
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:10 Topics: Acute Kidney Injury; Aged; Boronic Acids; Bortezomib; Combined Modality Therapy; Databases, Factual; Dexamethasone; Female; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Multiple Myeloma; Pyrazines; Renal Dialysis; Thalidomide	2012
High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy. American journal of hematology, 2012, Volume: 87, Issue:6 Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines; Renal Dialysis; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome	2012
[Improved prognosis in light chain nephropathy due to multiple myeloma]. Ugeskrift for laeger, 2012, Apr-23, Volume: 174, Issue:17 Topics: Acute Kidney Injury; Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Immunoglobulin lambda-Chains; Immunoglobulin Light Chains; Kidney Diseases; Middle Aged; Multiple Myeloma; Paraproteinemias; Prognosis; Pyrazines; Stem Cell Transplantation	2012
Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy. Irish medical journal, 2012, Volume: 105, Issue:5 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Combined Modality Therapy; Female; Humans; Ireland; Kidney Function Tests; Middle Aged; Multiple Myeloma; Pyrazines; Renal Dialysis	2012
Drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient taking sitagliptin. Diabetes & metabolism, 2012, Volume: 38, Issue:6 Topics: Acute Kidney Injury; Aged; Back; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Ear; Edema; Eosinophilia; Exanthema; Female; Glucocorticoids; Humans; Prednisone; Pyrazines; Sitagliptin Phosphate; Triazoles	2012
[Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:1 Topics: Acute Kidney Injury; Adult; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Cryoglobulinemia; Cryoglobulins; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Female; Fibrinogens, Abnormal; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Kidney; Leg Ulcer; Microscopy, Fluorescence; Necrosis; Paraproteinemias; Plasmapheresis; Prednisone; Pyrazines; Skin	2013
Pharmacokinetic changes of intravenous 2-(allylthio) pyrazine, a chemoprotective agent, in rats with acute renal failure induced by uranyl nitrate. Research communications in molecular pathology and pharmacology, 2002, Volume: 111, Issue:5-6 Topics: Acute Kidney Injury; Albumins; Animals; Area Under Curve; Blood Urea Nitrogen; Chromatography, High Pressure Liquid; Creatinine; Enzyme Inhibitors; Half-Life; Injections, Intravenous; Male; Organ Size; Proteins; Pyrazines; Rats; Rats, Sprague-Dawley; Uranyl Nitrate	2002
Effects of acute renal failure on the pharmacokinetics of oltipraz in rats. Journal of pharmaceutical sciences, 2004, Volume: 93, Issue:9 Topics: Acute Kidney Injury; Animals; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Thiones; Thiophenes	2004
Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of 2-(allylthio) pyrazine, a chemoprotective agent, in rats: the role of CYP3A23 induction. Research communications in molecular pathology and pharmacology, 2004, Volume: 115-116 Topics: Acute Kidney Injury; Animals; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Enzyme Induction; Kinetics; Male; Organometallic Compounds; Pyrazines; Rats; Rats, Sprague-Dawley	2004
Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma. Haematologica, 2007, Volume: 92, Issue:10 Topics: Acute Kidney Injury; Aged; Boronic Acids; Bortezomib; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines	2007
Uric acid and the kidney. Perspectives in nephrology and hypertension, 1976, Volume: 3 Topics: Acute Kidney Injury; Ammonia; Animals; Glomerular Filtration Rate; Glutamine; Gout; Humans; Hydrogen-Ion Concentration; Kidney; Kidney Calculi; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Metabolic Diseases; Pyrazines; Uric Acid	1976
[Acute renal failure after pteridine administration]. Klinische Wochenschrift, 1970, Oct-15, Volume: 48, Issue:20 Topics: Acute Kidney Injury; Animals; Anuria; Chlorothiazide; Diuretics; Folic Acid; Furosemide; Glomerular Filtration Rate; Kidney Function Tests; Kidney Tubules; Male; Pteridines; Pyrazines; Rats; Water-Electrolyte Balance; Xanthopterin	1970